Erratum: Expression of concern: Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma(PLoS ONE (2014) 9:6 (e99412)DOI:10.1371/journal.pone.0099412);Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yang, Chun Hung ^a,b   Wang, Hui Ling ^a,c   Lin, Yi Sheng ^a,c   Kumar, K P Shravan ^a,c   Lin, Hung Chi ^a,b   Chang, Chih Jung ^a,c   Lu, Chia Chen ^d   Huang, Tsung Teng ^a,c   Martel, Jan ^a   Ojcius, David M ^a,e   Chang, Yu Sun ^a   Young, John D ^a,f,g   Lai, Hsin Chih ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b TAIWAN AGRICULTURAL CHEMICALS AND TOXIC SUBSTANCES RESEARCH INSTITUTE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ROCKEFELLER UNIVERSITY   (United States)

^g MING CHI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BMI1 PROTEIN; CD24 ANTIGEN; CELL MARKER; CISPLATIN; DOCETAXEL; GELATINASE A; GELATINASE B; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; WNT PROTEIN; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; CD24 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BMI 1 GENE; CANCER CELL LINE; CANCER RESISTANCE; CANCER STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; IMMUNE DEFICIENCY; IN VITRO STUDY; NANOG GENE; NASOPHARYNX CARCINOMA; NONHUMAN; OCT4 GENE; PROTEIN FUNCTION; REX 1 GENE; SIGNAL TRANSDUCTION; SOX2 GENE; ANIMAL; CELL CLONE; CELL COUNT; CELL SEPARATION; DRUG RESISTANCE; ENZYMOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; NASOPHARYNX TUMOR; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE; TUMOR INVASION; WNT SIGNALING PATHWAY;

ANIMALS; ANTIGENS, CD24; ATP-BINDING CASSETTE TRANSPORTERS; CELL COUNT; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CLONE CELLS; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE, INBRED NOD; MICE, SCID; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; SPHEROIDS, CELLULAR; TUMOR MARKERS, BIOLOGICAL; WNT SIGNALING PATHWAY;

EID: 84903531308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0210304     Document Type: Erratum

References (66)

1. Cao SM, Simons MJ, Qian CN (2011) The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 30: 114-119.
2. Eduardo B, Raquel C, Rui M (2010) Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal. Eur Arch Otorhinolaryngol 267: 1607-1612.
3. Cancer Registry Annual Report R.O.C. Department of Health Executive Yuan, ROC. (2010).
4. Chang JT, Ko JY, Hong RL (2004) Recent advances in the treatment of nasopharyngeal carcinoma. J Formos Med Assoc 103: 496-510. (Pubitemid 39386607)
5. DeNittis AS, Liu L, Rosenthal DI, Machtay M (2004) Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy, and concurrent/adjuvant chemotherapy. Am J Clin Oncol 25: 93-95.
6. Suarez C, Rodrigo JP, Rinaldo A, Langendijk JA, Shaha AR, et al. (2010) Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol 267: 1811-1824.
7. Marotta LL, Polyak K (2009) Cancer stem cells: a model in the making. Current Opin Genet Dev 19: 44-50.
8. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344.
9. Reya T, Morrison SJ, Clarke MF, Weissman I (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111. (Pubitemid 33041634)
10. Assimakopoulos D, Kolettas E, Patrikakos G, Evangelou A (2002) The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas. Histol Histopathol 17: 1269-1281.
11. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, et al. (2008) The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 68: 9703-9711.
12. + cancer stem cells in human liver cancer. Cancer Cell 13: 153-166.
13. + cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 29: 2672-2680.
14. Facchino S, Abdouh M, Bernier G (2011) Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme. Cancers 3: 1777-1797.
15. Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, et al. (2011) Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 64: 937-946.
16. + cancer stem cells in lung cancer. Front Biosci 18: 447-453.
17. Tang DG (2012) Understanding cancer stem cell heterogeneity and plasticity. Cell Res 22: 457-472.
18. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, et al. (2006) Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24: 506-513. (Pubitemid 44464754)
19. Ho MM, Ng AV, Lam S, Hung JY (2007) Side population in human lung cancer cell lines and tumors in enriched with stem-like cancer cells. Cancer Research 67: 4827-4233.
20. Lanzkron SM, Collector MI, Sharkis SJ (1999) Hematopoietic Stem Cell Tracking In Vivo: A comparison of short-term and long-term repopulating cells. Blood 93: 1916-1921. (Pubitemid 29128493)
21. Wang WJ, Wu SP, Liu JB, Shi YS, Huang X, et al. (2013) MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells. Cancer Res 73: 1219-1231.
22. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH (2007) Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 67: 3716-3724. (Pubitemid 46762157)
23. + cells in human nasopharyngeal carcinoma cell line. Arch Med Res 42: 15-21.
24. Zhang XG, Gaillard JP, Robillard N, Lu ZY, Gu ZJ, et al. (1994) Obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83: 3654-3663. (Pubitemid 24175556)
25. International Stem Cell Initiative, Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, et al. (2007) Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25: 803-816.
26. Liu AY (2000) Differential expression of cell surface molecules in prostate cancer cells. Cancer Res 60: 3429-3434.
27. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372-376. (Pubitemid 30187435)
28. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR (2007) OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 120: 1598-1602. (Pubitemid 46355399)
29. Kim JH, Jee MK, Lee SY, Han TH, Kim BS, et al. (2009) Regulation of adipose tissue stromal cell behaviors by endogenic Oct4 expression control. PLoS One 4: e7166.
30. Guo Y, Liu S, Wang P, Zhao S, Wang F, et al. (2011) Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology 59: 763-775.
31. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, et al. (2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440.
32. Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255-260. (Pubitemid 40852690)
33. Etti BS, James RT, Lorraine J, Yehudit B (1998) Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol 18: 1866-1878.
34. Corrêa S, Binato R, Du Rocher B, Castelo-Branco MT, Pizzatti L, et al. (2012) Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia. BMC Cancer 12: 303-313.
35. Prosperi JR, Goss KH (2010) A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer. Curr Drug Targets 11: 1074-1088.
36. Larue L, Delmas V (2006) The WNT/beta-catenin pathway in melanoma. Front Biosci 11: 733-742. (Pubitemid 43258176)
37. Greenspan EJ, Madigan JP, Boardman LA, Rosenberg DW (2011) Ibuprofen inhibits activation of nuclear β-catenin in human colon adenomas and induces the phosphorylation of GSK-3β. Cancer Prev Res 4: 161-171.
38. Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, et al. (2008) Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol 4: 647-660.
39. Cai C, Zhu X (2012) The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Mol Med Rep 5: 1191-1196.
40. Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, et al. (2011) β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 20: 741-754.
41. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, et al. (2004) A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228-14233. (Pubitemid 39305058)
42. Zhang JT (2007) Biochemistry and pharmacology of the human multidrug resistance gene product, ABCG2. J Cent South Univ (Med Sci) 32: 531-541.
43. Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, et al. (2002) The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8: 22-28. (Pubitemid 34101455)
44. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T (2005) Opinion: Migrating cancer stem cells-An integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749. (Pubitemid 41486367)
45. Hollier BG, Evans K, Mani SA (2009) The epithelial-to-mesenchymal transition and cancer stem cells: A coalition against cancer therapies. J Mammary Gland Biol Neoplasia 14: 29-43.
46. Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34. (Pubitemid 43723979)
47. Aigner S, Ramos CL, Hafezi-Moghadam A, Lawrence MB, Friederichs J, et al. (1998) CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 12: 1241-1251. (Pubitemid 28418954)
48. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037.
49. Gao MQ, Choi YP, Kang S, Youn JH, Cho NH (2010) CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 29: 2672-2680.
50. Wei X, Dombkowski D, Meirelles K, Pieretti-Vanmarcke R, Szotek PP, et al. (2010) Müllerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci USA 107: 18874-18879.
51. Zhang S, Balch C, Chan MW, Lai HC, Matei D, et al. (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320.
52. Campbell PA, Perez-Iratxeta C, Andrade-Navarro MA, Rudnicki MA (2007) Oct4 targets regulatory nodes to modulates stem cell function. PLoS One 2: e553.
53. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
54. Song LB, Li J, Liao WT, Feng Y, Yu CP, et al. (2009) The polycomb group Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-3636.
55. Yi F, Pereira L, Hoffman JA, Shy BR, Yuen CM, et al. (2011) Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. Nat Cell Biol 13: 762-770.
56. Marie Rattis F, Voermans C, Reya T (2004) Wnt signaling in the stem cell niche. Curr Opin Hematol 11: 88-94. (Pubitemid 38951226)
57. Herzig M, Savarese F, Novatchkova M, Semb H, Christofori G (2007) Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene 26: 2290-2298. (Pubitemid 46572820)
58. Moriyama T, Ohuchida K, Mizumoto K, Cui L, Ikenaga N, et al. (2010) Enhanced cell migration and invasion of CD133 (+) pancreatic cancer cells co-cultured with pancreatic stromal cells. Cancer 116: 3357-3368.
59. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostste cancer stem cell. Cancer Res 65: 10946-10951. (Pubitemid 41713363)
60. Yong VW, Power C, Forsyth P, Edwards D (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2: 502-511. (Pubitemid 33676585)
61. Zhou G, Zhai Y, Cui Y, Qiu W, Yang H, et al. (2007) Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Hum Mutat 28: 1091-1097. (Pubitemid 350036913)
62. Lu J, Chua HH, Chen SY, Chen JY, Tsai CH (2003) Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Cancer Res 63: 256-262. (Pubitemid 36070448)
63. Hou W, He W, Li Y, Ma R, Wang Z, et al. (2014) Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness. Eur Arch Otorhinolaryngol 271: 171-179.
64. Chu WK, Dai PM, Li HL, Pao CC, Chen JK (2013) Nanog expression is negatively regulated by protein kinase C activities in human cancer cell lines. Carcinogenesis 34: 1497-1509.
65. Luo W, Li S, Peng B, Ye Y, Deng X, et al. (2013) Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS One 8: e56324.
66. Guo D, Xu BL, Zhang XH, Dong MM (2012) Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line cne-2 possess epithelial mesenchymal transition properties in association with metastasis. Oncol Rep 28: 241-247.